Clinical trial
A Phase 3, Multi-center, Randomized, Double-Blind, Vehicle-controlled Study to Evaluate the Efficacy and Safety of Topical Administration of Minocycline Hydrochloride Foam (4%) in the Treatment of Moderate-to-Severe Acne Vulgaris
NCT04960930 is registered in ClinicalTrials.gov with Cutia Therapeutics (Shanghai) Co., Ltd as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Multi-center, Randomized, Double-Blind, Vehicle-controlled Study to Evaluate the Efficacy and Safety of Topical Administration of Minocycline Hydrochloride Foam (4%) in the Treatment of Moderate-to-Severe Acne Vulgaris
- Lead sponsor
- Cutia Therapeutics (Shanghai) Co., Ltd
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 17, 2021
- Completion date
- October 14, 2022
- Enrollment
- 372 (actual)
- Sites
- 29
Conditions
As the registry lists them; a condition with its own page is linked.